Gary Aston Jones: Treating Addiction With Dual Orexin Receptor Antagonists

Unlocking the Secrets of Sleep and Addiction: A Conversation with Dr. Gary Aston-Jones<br /><br />In this episode, we are happy to welcome Dr. Gary Aston-Jones, Director of the Rutgers Brain Health Institute and head of the Aston-Jones Lab. Dr. Aston-Jones has dedicated his career to unraveling the mysteries of the brain and exploring how understanding the connection between sleep and addiction could lead to innovative treatments. Join us as we dive deep into the world of dual orexin receptor antagonists, a class of sleeping medications with promising potential for treating drug addiction.<br /><br />Dr. Aston-Jones begins by shedding light on the crucial role of orexin, a neuropeptide that regulates arousal, wakefulness, and appetite, and how it is intricately linked to the complex process of addiction. He explains how the orexin system can be targeted using dual orexin receptor antagonists, which are designed to selectively block orexin receptors in the brain. By doing so, these medications not only promote sleep but also demonstrate intriguing possibilities for reducing cravings and drug-seeking behavior in individuals struggling with addiction.<br /><br />As we delve deeper into the conversation, Dr. Aston-Jones shares fascinating insights from his research on the efficacy of dual orexin receptor antagonists in animal models. He discusses the implications of these findings for the development of new therapies and highlights the unique advantages of this class of medications in addressing both sleep disturbances and addiction.<br /><br />We also explore the potential challenges and limitations of dual orexin receptor antagonists, including possible side effects, concerns about developing dependence on the medication, and the need for further clinical trials. Dr. Aston-Jones emphasizes the importance of a holistic approach to treating addiction, incorporating pharmacological interventions, behavioral therapies, and support systems to optimize outcomes.<br /><br />Finally, Dr. Aston-Jones shares his vision for t